New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 4, 2013
15:30 EDTMDVNAdage Capital Partners reports 5.37% passive stake in Medivation
News For MDVN From The Last 14 Days
Check below for free stories on MDVN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
11:41 EDTMDVNCubist rises after report sparks takeover interest speculation
Subscribe for More Information
August 8, 2014
08:27 EDTMDVNMedivation price target raised to $105 from $100 at Brean Capital
Brean Capital raised its price target on Medivation to $105 from $100 following its Q2 report, citing raised guidance for Xtandi sales, royalties, and milestone payments and the potential for Xtandi to receive FDA approval in September to be used in the pre-chemo setting. Brean keeps it Buy rating on the stock.
07:33 EDTMDVNMedivation price target raised to $90 from $85 at UBS
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use